Pacer Advisors, Inc. Rhythm Pharmaceuticals, Inc. Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$35.41 - $44.37 $21,423 - $26,843	-605 Reduced 59.43%	413 $16,000
Q1 2024 May 10, 2024	BUY	$39.12 - $52.44 $39,824 - $53,383	1,018 New	1,018 $44,000
Q2 2021 Jul 21, 2021	SELL	$18.52 - $22.55 $52,689 - $64,154	-2,845 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$20.25 - $39.49 $29,605 - $57,734	1,462 Added 105.71%	2,845 $61,000
Q4 2020 Jan 20, 2021	BUY	$21.17 - $32.61 $9,145 - $14,087	432 Added 45.43%	1,383 $41,000
Q3 2020 Oct 19, 2020	BUY	$18.13 - $30.61 $17,241 - $29,110	951 New	951 $21,000
Q4 2018 Feb 13, 2019	SELL	$24.11 - $31.34 $38,768 - $50,394	-1,608 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$26.99 - $35.85 $43,399 - $57,646	1,608 New	1,608 $47,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.34B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.